Certest Pharma is thrilled to announce that we have officially joined the prestigious Alliance for mRNA Medicines. This marks a significant step in our ongoing commitment to advancing RNA-based therapies and drug delivery systems.

The Alliance for mRNA Medicines is a key coalition of leading organizations dedicated to accelerating the development and application of mRNA technologies. This alliance brings together experts from the fields of biotechnology, pharmaceuticals, and academia to push the boundaries of mRNA science and address critical medical challenges.

By joining this influential network, Certest Pharma strengthens its position at the forefront of RNA therapeutics. With our CEO Nelson Fernandes representing us in this esteemed group, we are better poised to contribute to groundbreaking advancements in mRNA drug delivery, therapeutic applications, and cutting-edge innovations in the biotech sector.

We are proud to be part of a movement that is shaping the future of medicine and look forward to the opportunities and collaborations that lie ahead.